Hepatitis B virus X protein protects hepatoma and hepatic cells from complement‐dependent cytotoxicity by up‐regulation of CD46

[1]  Sachiyo Yoshio,et al.  [Immunopathogenesis of hepatitis B virus infection]. , 2015, Nihon rinsho. Japanese journal of clinical medicine.

[2]  Youliang Wang,et al.  Hepatitis B virus X protein modulates oncogene yes‐associated protein by CREB to promote growth of hepatoma cells , 2012, Hepatology.

[3]  Yijia Li,et al.  Hepatitis B virus/human immunodeficiency virus coinfection: interaction among human immunodeficiency virus infection, chronic hepatitis B virus infection, and host immunity. , 2012, Chinese medical journal.

[4]  Yumei Du,et al.  Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18* , 2012, The Journal of Biological Chemistry.

[5]  D. Hafler,et al.  Prostaglandin E2 Affects T Cell Responses through Modulation of CD46 Expression , 2012, The Journal of Immunology.

[6]  E. Ratner,et al.  Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy , 2012, British Journal of Cancer.

[7]  Y. Zhang,et al.  HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF‐κB signaling to protect breast cancer cells from complement attack , 2012, FEBS letters.

[8]  Yumei Du,et al.  Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. , 2011, Carcinogenesis.

[9]  T. Giese,et al.  Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. , 2010, Current cancer drug targets.

[10]  W. Sung,et al.  Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. , 2010, Journal of hepatology.

[11]  Jie Zheng,et al.  Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 , 2010, Cell Research.

[12]  Qiang Liu,et al.  A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. , 2010, Neoplasia.

[13]  T. Giese,et al.  Primary human hepatocytes are protected against complement by multiple regulators. , 2009, Molecular immunology.

[14]  R. Xiang,et al.  Gene expression profiles of human liver cells mediated by hepatitis B virus X protein , 2009, Acta Pharmacologica Sinica.

[15]  Mu-jun Zhao,et al.  Hepatitis B virus X protein sensitizes cells to starvation‐induced autophagy via up‐regulation of beclin 1 expression , 2009, Hepatology.

[16]  Hua Yu,et al.  Activated Signal Transducers and Activators of Transcription 3 Signaling Induces CD46 Expression and Protects Human Cancer Cells from Complement-Dependent Cytotoxicity , 2007, Molecular Cancer Research.

[17]  S. Kaneko,et al.  Molecular functions and biological roles of hepatitis B virus x protein , 2006, Cancer science.

[18]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[19]  Lei-Chin Chen,et al.  Functional role of NF-IL6β and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene , 2006, Nucleic acids research.

[20]  T. Wright.  Introduction to Chronic Hepatitis B Infection , 2006, The American Journal of Gastroenterology.

[21]  S. Meri,et al.  Ascitic complement system in ovarian cancer , 2005, British Journal of Cancer.

[22]  Enrique Lara-Pezzi,et al.  Implicación de la proteína HBx del virus de la hepatitis B en la respuesta inmune y la progresión tumoral , 2003 .

[23]  E. Lara-Pezzi,et al.  [Role of the hepatitis B virus X protein (HBx) in immune response and tumoral progression]. , 2003, Gastroenterology & hepatology.

[24]  Z. Fishelson,et al.  Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. , 2003, Molecular immunology.

[25]  P. Martínez,et al.  Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. , 2003, Cellular immunology.

[26]  A. Levine,et al.  Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling Pathway , 2002 .

[27]  A. Levine,et al.  Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. , 2002, Biochemical and biophysical research communications.

[28]  M. Kirschfink.  Targeting complement in therapy , 2001, Immunological reviews.

[29]  O. Spiller,et al.  Cytokine‐mediated up‐regulation of CD55 and CD59 protects human hepatoma cells from complement attack , 2000, Clinical and experimental immunology.

[30]  N. Cheung,et al.  CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma. , 2000, Cancer research.

[31]  K. Nouso,et al.  Expression of membrane cofactor protein (MCP, CD46) in human liver diseases , 1999, British Journal of Cancer.